Science ❯ Psychology ❯ Psychedelics

Clinical Trials

DMT Research Therapeutic Use Psilocybin Research PTSD Treatment

Compass Pathways Rises on Q1 Beat as FDA Accepts Rolling Review for COMP360

The next milestone is a 26-week Phase 3 data readout in early Q3.

Single IV Dose of DMT Shows Rapid, Lasting Antidepressant Effects in Small Trial